Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 28, 2008; 14(20): 3224-3230
Published online May 28, 2008. doi: 10.3748/wjg.14.3224
Published online May 28, 2008. doi: 10.3748/wjg.14.3224
Number of patients (%) | ||
Age (mean ± SD) | 62.6 ± 13 | |
Range (yr) | 28-91 | 61/39 |
Male/Female | 34/22 | |
Diabetes (Yes/No) | 14/41 | 25/75 |
BMI (kg/m2) | ||
< 25 | 18 | 35 |
25-30 | 16 | 31 |
≥ 30 | 18 | 35 |
Not available | 3 | |
History of cholelithiasis (Yes /No) | 17/38 | 31/69 |
Clinical manifestations | ||
Jaundice | 40 | 72.7 |
Dark urine | 34 | 61.8 |
Weight loss | 24 | 43.6 |
Abdominal pain | 24 | 43.6 |
Total bilirubin | ||
< 10 mg/dL | 27 | 49 |
≥ 10 mg/dL | 17 | 31 |
Missing | 11 | 20 |
AJCC staging | ||
I | 1 | |
II | 1 | |
III | 0 | |
IV | 49 | 89 |
Missing | 4 | |
Surgery | ||
Yes | 21 | 38 |
No | 34 | 62 |
Adjuvant chemotherapy | ||
Yes | 14 | 25 |
No | 41 | 75 |
- Citation: Farhat MH, Shamseddine AI, Tawil AN, Berjawi G, Sidani C, Shamseddeen W, Barada KA. Prognostic factors in patients with advanced cholangiocarcinoma: Role of surgery, chemotherapy and body mass index. World J Gastroenterol 2008; 14(20): 3224-3230
- URL: https://www.wjgnet.com/1007-9327/full/v14/i20/3224.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3224